Detalles de la búsqueda
1.
Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway.
BMC Psychiatry
; 22(1): 181, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35291968
2.
Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016-2020.
Health Qual Life Outcomes
; 19(1): 69, 2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653349
3.
Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders.
Sci Rep
; 14(1): 816, 2024 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191795
4.
The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial.
Subst Abuse Treat Prev Policy
; 18(1): 25, 2023 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37095561
5.
Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020.
Subst Abuse Treat Prev Policy
; 16(1): 67, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526054
6.
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020.
Subst Abuse Treat Prev Policy
; 15(1): 93, 2020 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33317568
7.
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017.
Subst Abuse Treat Prev Policy
; 15(1): 44, 2020 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32605625
Resultados
1 -
7
de 7
1
Próxima >
>>